GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Homeless man accused of attack on SF mayor’s bodyguard is chucked in jail again — days after release
Tony Phillips, a 44-year-old homeless man who was released from jail after being charged with attacking San Francisco Mayor Daniel Lurie's bodyguard, is reportedly back behind bars. ...
Kwamaine Jerell Ford, 34, of Buford, was charged in connection with the mastermind scheme targeting a slew of professional athletes that he started while in prison in November 2020, the U.S. Attorney'...
